Viewing Study NCT06168734


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-06-27 @ 11:48 PM
Study NCT ID: NCT06168734
Status: WITHDRAWN
Last Update Posted: 2025-06-08
First Post: 2023-12-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
Sponsor: Venatorx Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: VNRX-5133-301
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None FED View